Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Preliminarily Evaluate the Efficacy and Safety of SYH2085 Tablets in Chinese Adult Participants With Uncomplicated Influenza

NCT07798193 is registered in ClinicalTrials.gov with CSPC ZhongQi Pharmaceutical Technology Co., Ltd. as lead sponsor.

NCT NCT07798193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07798193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Preliminarily Evaluate the Efficacy and Safety of SYH2085 Tablets in Chinese Adult Participants With Uncomplicated Influenza
Lead sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 10, 2026
Completion date
June 30, 2027
Enrollment
213 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

influenza